Certified by Founder Lodge
Tessera Therapeutics
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $300,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our mission is to cure disease by writing the code of life
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 19 ,2022 | Series C | $300,000,000 |
Hanwha Impact Partners
March Capital
T. Rowe Price
Alaska Permanent Fund Corporation
ARTIS Ventures
Flagship Pioneering
Longevity Vision Fund
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Malama Health | $9,200,000 | (Mar 17, 2026)
Gangkhar | $4,250,000 | (Mar 17, 2026)
Dark Watch | $3,500,000 | (Mar 17, 2026)
Great Sky | $14,000,000 | (Mar 17, 2026)
Scanner | $22,000,000 | (Mar 17, 2026)
